Optimal control of therapies related to an oxytaxis glioblastoma model
Abstract
We propose and analyze an optimal control problem associated with a Keller-Segel type parabolic system with chemoattraction, modeling the glioblastoma growth in a bi-dimensional bounded domain, influenced by the presence of oxygen where the controls are two different (chemotherapy and antiangiogenic) therapies. The model considers the random diffusion of tumor cells and oxygen, the movement of cells towards the oxygen gradient (oxytaxis), and reaction terms describing the interaction between cel...
Description / Details
We propose and analyze an optimal control problem associated with a Keller-Segel type parabolic system with chemoattraction, modeling the glioblastoma growth in a bi-dimensional bounded domain, influenced by the presence of oxygen where the controls are two different (chemotherapy and antiangiogenic) therapies. The model considers the random diffusion of tumor cells and oxygen, the movement of cells towards the oxygen gradient (oxytaxis), and reaction terms describing the interaction between cells and oxygen. We establish a mathematical framework to analyze the existence and uniqueness of weak-strong solution of the model and subsequently we analyze an optimal control problem considering a cost functional that minimizes both the tumor growth and the oxygen concentration. We prove the existence of a global optimal solution and derive necessary first-order optimality conditions. Finally, we propose a methodology for approximating the optimal therapies. We use the gradient of the reduced cost functional through the adjoint scheme, and minimize the cost functional implementing the Adam gradient optimization method. Some numerical experiments are provided to demonstrate the effectiveness of the proposed scheme.
Source: arXiv:2604.21674v1 - http://arxiv.org/abs/2604.21674v1 PDF: https://arxiv.org/pdf/2604.21674v1 Original Link: http://arxiv.org/abs/2604.21674v1
Please sign in to join the discussion.
No comments yet. Be the first to share your thoughts!
Apr 24, 2026
Mathematics
Mathematics
0